Category Archives

2 Articles

Posted by admin on

Sahm Adrangi – Standing Strong Against Corruption

Sahm Adrangi is the visionary behind Kerisdale Capital Management LLC in New York. He functions as Chief Executive Officer at the company. Kerrisdale was formed in 2009. Mr. Adrangi initiated the formation of the group with less than 1 million dollars. The company has shown massive growth over the years and is responsible for the management of 150 million dollars at present. Kerrisdale is involved in the process of short selling stocks. It also deals with investment research and has made several lucrative transactions with companies such as Adamas Pharmaceutical, Pulse Biosciences Inc and Straight Path Communications Inc.



Sahm Adrangi’s expertise in investment was brought to light when he revealed dishonest dealing by several China-based firms, such as Lihua International, China-Biotics, and China Marine Food Group. Mr. Sahm Adrangi next divulged research about biotechnology firms. In particular, he focused on Zafgen, Sage Therapeutics and a few others. He analysis has also been instrumental in uncovering facets of organizations such as Norther Dynasty Minerals and First Majestic Silver. Sahm Adrangi has also unveiled aspects of firms such as Viasat Inc, Dish Network and GlobalStarbelonging to the telecommunications sphere.



Sahm Adrangi was recently in the news when he took a stand on corruption. This was accomplished through the unique position of accumulating a whopping 100 million dollars in opposition to a company. This is to expose the misdealings of this enterprise in the past.



Sahm Adrangi studied from Yale University. He has significant experience in the field of investment. He has worked with prestigious companies such as Longacre Fund Management LLC, serving as its Investment Analyst. He tremendous skill in finances developed through his work at Paulson and Co followed by Bowery Investment management. Sahm Adrangi has also worked at Chanin Capital Partners. He gained experience in bankruptcy while working at this film. His role was to provide solutions for bankruptcy and shareholder issues. He has worked at Deutsche bank too, where he helped to reframe and control bonds and finances. He is also a prolific speaker and has lent voice to his opinions via forums such as Distressed Debt Investing Conference and the Value Investing Conference.




See This Page for related information.


Posted by admin on

Sahm Adrangi Invests Differently

While many think it’s impossible to fight big business as an individual, hedge fund and activist investor Sahm Adrangi is proving that isn’t the case. Also known as a value investor, Adrangi makes bets against bad companies in the mining, telecommunications, and biotech sectors with his company Kerrisdale Capital Management LLC. As Chief Investment Officer and founder, he raised $100 million to bet against and lead a short selling attack against a single biotech company hyping a bad drug in development. At the time, his particular brand of investing was some of the first of its kind.


In 2017, 2 of the drugs in development in which Adrangi released research foretelling their failure did just that. They both failed horribly in Phase III testing, but not before receiving millions in investments that were all based on shoddy and misrepresented test results from Phase I and II. Sahm Adrangi’s short selling and the negative results that showed the drugs weren’t any better for the diseases they were supposed to treat than sugar pills caused the biotech companies Bavarian Nordic and Sage Therapeutics to drop by 50 and 20 percent very quickly.


The drugs in question, a prostate cancer vaccine and a treatment for a rare type of epilepsy, failed in Phase III within weeks of each other. Now, with Phase III testing of another drug, a treatment for AL amyloidosis being developed by Prothena, that Sahm Adrangi is betting against, investors are listening. Quickly after Sahm released his research showing that the results showing improvement in the incurable illness are most likely just the results of random results and changes in the disease, Prothena’s shares values fell by around 8%.


Before founding Kerrisdale Capital Management in April 2009, the 2003 Yale University graduate worked as an analyst for companies such as Longacre Fund Management LLC and Chanin Capital Management where he was entrusted with $2 billion of distressed debt and worked in a bankruptcy restructuring group. While at Yale, the former avid protestor became quickly disenchanted with his peer’s methods of activism. Sahm Adrangi recounted that they expected anyone involved to share the same belief structure as a whole and any deviation was looked down upon. Now he’s making a change in a different way and the world is taking notice. Visit This Page for more information.